by Benzinga Insights | Aug 28, 2026 | General
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 7.78% on an annualized basis producing an average annual return of 21.28%. Currently, Cytokinetics has a market capitalization of $10.34 billion. Buying $100 In CYTK: If an investor had...
by Erica Kollmann | Aug 28, 2026 | General
IREN Ltd. (NASDAQ:IREN) told investors on its earnings call Thursday that this year’s data center capacity is essentially spoken for, shifting the conversation toward the 2027 and 2028 buildouts. IREN stock is moving. See the real-time price action here. IREN...
by Kaustubh Bagalkote | Aug 28, 2026 | General
HP Inc. (NYSE:HPQ) stock is recovering and trending upward on Friday. Investors are recalibrating positions after a volatile post-earnings decline. The stock initially fell after the release of its third-quarter financial results, but buyers are stepping back in to...
by Avi Kapoor | Aug 28, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Argus Research analyst John Eade upgraded Moderna Inc...
by Benzinga Insights | Aug 28, 2026 | General
Coeur Mining (NYSE:CDE) has outperformed the market over the past 5 years by 13.41% on an annualized basis producing an average annual return of 24.71%. Currently, Coeur Mining has a market capitalization of $21.86 billion. Buying $100 In CDE: If an investor had...
Recent Comments